Sylentis S.A. - Product Pipeline Review - 2014 -- NEW YORK, Nov. 12, 2014 /PRNewswire/ -- Global Markets Direct's, 'Sylentis S.A. - Product Pipeline Review - 2014', provides an overview of the Sylentis S.A.'s pharmaceutical research and development focus. This report provides comprehensive information on the current therapeutic developmental pipeline of Sylentis S.A.'s, complete with comparative analysis at various stages, therapeutics assessment by drug target, mechanism of action (MoA), route of administration (RoA) and molecule type. It also reviews latest updates, and featured news and press releases, along with special features on late-stage and discontinued projects. The report provides brief overview of Sylentis S.A. including business description, key information and facts, and its locations and subsidiaries - The report reviews current pipeline of Sylentis S.A.'s human therapeutic division and enlists all their major and minor projects - The report features product description and descriptive mechanism of action for key pipeline products along with the product's developmental history and major milestones - Special feature on out-licensed and partnered product portfolio - The report summarizes all the dormant and discontinued pipeline projects - Latest company statement - Latest news and deals relating to the Sylentis S.A.'s pipeline products Evaluate Sylentis S.A.'s strategic position with total access to detailed information on its product pipeline - Assess the growth potential of Sylentis S.A. in its therapy areas of focus - Identify new drug targets and therapeutic classes in the Sylentis S.A.'s R&D portfolio and develop key strategic initiatives to reinforce pipeline in those areas - Exploit in-licensing opportunities by identifying windows of opportunity to fill portfolio gaps - Develop strategic initiatives by understanding the focus areas of Sylentis S.A. and exploit collaboration and partnership opportunities - Identify emerging players with potentially strong product portfolio and create effective counter-strategies to gain competitive advantage - Plan mergers and acquisitions effectively by identifying the most promising pipeline of Sylentis S.A. - Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope - Explore the dormant and discontinued projects of Sylentis S.A. and identify potential opportunities in those areas - Avoid Intellectual Property Rights related issues Read the full report: http://www.reportlinker.com/p02459414-summary/view-report.html